OSCA - Olaparib Standard of CAre Study

Clinical trial NCT02262273 · COMPLETED

Trial details

NCT number: NCT02262273
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Platinum-sensitive Recurrent Serous Ovarian Cancer

Start date: 2014-10-01
Primary completion: 2016-04-01
Enrollment: 2123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.